Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
06/2003
06/12/2003US20030108965 Using polypeptide, detection of antibody; cancer of ovaries
06/12/2003US20030108964 Caspase-inhibitory-factor(cif)and uses thereof
06/12/2003US20030108961 Methods and compositions for diagnosing breast cancer
06/12/2003US20030108959 Treating diseases mediated by metalloprotease-shed proteins
06/12/2003US20030108958 Controlling gene expression; antiinflammatory agents, anticancer agents, autoimmune disease
06/12/2003US20030108957 Biocidal molecules, macromolecular targets and methods of production and use
06/12/2003US20030108953 Truncated egf receptor
06/12/2003US20030108951 Screening drugs using antigens; suppress gene expression
06/12/2003US20030108950 Measuring concentration in body fluid of tumor antibodies
06/12/2003US20030108942 Methods for treatment of HIV and other infections using a T cell or viral activator and anti-retroviral combination therapy
06/12/2003US20030108928 MID 241 receptor, a novel G-protein coupled receptor
06/12/2003US20030108927 Compositions and methods for the prevention, treatment and detection of tuberculosis and other diseases
06/12/2003US20030108923 Blocking gene expression
06/12/2003US20030108920 Tumor suppressor-like proteins that bind IGFBP2
06/12/2003US20030108914 Amplification of nucleic acids
06/12/2003US20030108912 Liver enriched transcription factor
06/12/2003US20030108907 Nucleic acids, proteins, and antibodies
06/12/2003US20030108906 Signal transduction, gene expression of pain sequences; genetic engineering
06/12/2003US20030108904 Novel scavenger receptors
06/12/2003US20030108894 Novel polypeptide-atp-dependent helicase protein 68 and the polynucleotide encoding said polypeptide
06/12/2003US20030108885 Methods and compositions for the production of orthogonal tRNA-aminoacyltRNA synthetase pairs
06/12/2003US20030108883 Protein tyrosine phosphatase 1B (PTP1B); insulin resistance
06/12/2003US20030108882 Nucleic acid encoding a retinoblastoma binding protein (RBP-7) and polymorphic markers associated with said nucleic acid
06/12/2003US20030108623 Cancer treatment composition and method using signal transduction modulators and natural plant essential oils as synergists for conventional treatments
06/12/2003US20030108622 Prophylactic or therapeutic treatment of soft tissue cancer, e.g. breast cancer; improving the effective treatment and reducing the adverse side effects of current anticancer therapy; antiproliferative, -carcinogenic agents
06/12/2003US20030108619 Synergistic mixture of casein polypeptide to promote calcium absorption and genistein which inhibits bone resorption and promotes osteogenesis; prevent decrease in bone density and onset of osteoporosis
06/12/2003US20030108611 Bioactive particulates having a cationic surfactant adsorbed on their surfaces to provide superior adhesion to a biological substrate, e.g., an insect, teeth, bone, nails, chitin, feathers, plants, mucous, skin; drug delivery
06/12/2003US20030108596 Lipophilic drug compositions
06/12/2003US20030108586 Using gonadotropin releasing hormone antagonist
06/12/2003US20030108568 Antidiabetic agents
06/12/2003US20030108567 Antidiabetic agents
06/12/2003US20030108564 Method of preventing T cell-mediated responses by the use of the major histocompatibility complex class II analog protein (map protein) from Staphylococcus aureus
06/12/2003US20030108562 Administering gag protein; vaccines for human immunodeficiency virus
06/12/2003US20030108561 Core-glycosylated HCV envelope proteins
06/12/2003US20030108559 Induction immunology response; cardiovascular disorders, anticholesterol agents
06/12/2003US20030108558 Anticholesterol agents; rheumatic diseases; mutiple sclerosis; antidiabetic agents; administering protein extracted from animal liver
06/12/2003US20030108555 Using monoclonal antibodies; immunotherapy; mixture of virus and transfer factor
06/12/2003US20030108554 GIPs, a family of polypeptides with transcription factor activity that interact with goodpasture antigen binding protein
06/12/2003US20030108552 Genetic engineered polypeptides; rheumatic diseases, sepsis, viricides
06/12/2003US20030108549 Methods and compositions for modulating interleukin-21 receptor activity
06/12/2003US20030108548 Methods and materials for modulation of the immunosuppressive activity and toxicity of monoclonal antibodies
06/12/2003US20030108547 Methods of inhibiting the binding of a CD8+ T cell to a class I MHC employing a modified beta 2 microglobulin
06/12/2003US20030108546 Apoptosis-inducing single-chain Fv
06/12/2003US20030108545 Combination methods of inhibiting tumor growth with a vascular endothelial growth factor receptor antagonist
06/12/2003US20030108544 Compositions and methods for the diagnosis and treatment of tumor
06/12/2003US20030108541 Plant extract
06/12/2003US20030108540 Inducing apoptosis in tissues; binding antibodies
06/12/2003US20030108539 Cell-permeable peptide inhibitors of the JNK signal transduction pathway
06/12/2003US20030108538 LLG polypeptides of the triacylglycerol lipase family, and compositions and methods for their use in enzymatic hydrolysis, and protein and gene therapies
06/12/2003US20030108531 Genes for transfection into bony tissues
06/12/2003US20030108530 Antisense inhibiting melanoma invasion and functional analogs thereof
06/12/2003US20030108528 Detection of antigens due to injury, disease; promote regeneration of nervous system
06/12/2003US20030108525 Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewith
06/12/2003US20030108523 Controlling proliferation of mesothelioma cells; anticancer agent
06/12/2003US20030108519 Genetic engineered interferons; mucous membrane administering; stimulation of immunology response
06/12/2003US20030108516 Death domain containing receptor 4
06/12/2003US20030108514 Chemokines as adjuvants
06/12/2003CA2473727A1 Storage-stable fibrin sealant
06/12/2003CA2469671A1 A process for the preparation of a non-toxic anthrax vaccine
06/12/2003CA2469524A1 Adipocyte differentiation-related gene and protein
06/12/2003CA2469356A1 Nuclear protein "shoca" - a component of the wnt signalling pathway
06/12/2003CA2469151A1 Immunocytokines with modulated selectivity
06/12/2003CA2469134A1 Novel peptide and pharmaceutical use of the same
06/12/2003CA2469130A1 Peptide isosteres containing a heterocycle useful in the treatment of alzheimer's disease
06/12/2003CA2469092A1 Copolymer 1 vaccine and methods for treatment of amyotrophic lateral sclerosis (als)
06/12/2003CA2469078A1 Immunotherapeutic methods and systems
06/12/2003CA2468996A1 Use of fpt inhibitors and at least two antineoplastic agents in the treatment of cancer
06/12/2003CA2468991A1 Methods and reagents for diagnosis and treatment of diabetes
06/12/2003CA2468967A1 N-aryl-n'-arylcycloalkyl-urea derivatives as mch antagonists for the treatment of obesity
06/12/2003CA2468944A1 Migration of hematopoietic stem cells and progenitor cells to the liver
06/12/2003CA2468935A1 Adjuvanted antigenic meningococcal compositions
06/12/2003CA2468907A1 Effectors of innate immunity
06/12/2003CA2468851A1 Gips, a family of polypeptides with transcription factor activity that interact with goodpasture antigen binding protein
06/12/2003CA2468739A1 Suppression of polymeric alleles
06/12/2003CA2468701A1 T-bet compositions and methods of use thereof
06/12/2003CA2468698A1 Methods and compositions for modulating the immune system and uses thereof
06/12/2003CA2468678A1 Modulation of immune-cell related disorders using il-1hy2
06/12/2003CA2468556A1 Cyclodextrin grafted biocompatible amphiphilic polymer and methods of preparation and use thereof
06/12/2003CA2467738A1 Antibodies against carboxic anhydrase ix (ca ix) tumor antigen
06/12/2003CA2467073A1 Peptides and method for detecting alzheimer's disease and differentiating alzheimer's disease from other demential diseases
06/12/2003CA2466697A1 Pharmaceutical compositions containing 3,4-propinoperhydropurines and uses thereof for blocking neuronal transmission
06/12/2003CA2466542A1 Methods and compositions for use in pet breeding
06/12/2003CA2464897A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
06/12/2003CA2462966A1 Factor viii c2 domain variants
06/12/2003CA2462909A1 Methods for the treatment of hyperpigmentation of skin
06/11/2003EP1318407A1 Use of aldose-1-epimerase (mutarotase) for the diagnosis and therapy of infections and sepsis
06/11/2003EP1318401A2 Method for the early detection of the seroconversion of an anti hepatitis C virus antibody
06/11/2003EP1318198A1 Process for producing a recombinant polypeptide involving the addition of an inhibitor of chymotrypsins to the cell culture medium
06/11/2003EP1317930A1 Antithrombin for prevention and therapy of vascular proliferative diseases
06/11/2003EP1317929A2 Combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis c infection
06/11/2003EP1317915A1 Hair nourishments and method of screening the same
06/11/2003EP1317562A2 Test systems based on transmembrane receptors from helminths and the use thereof for identifying and characterizing compounds
06/11/2003EP1317556A1 Fusion protein from antibody cytokine-cytokine inhibitor (selectokine) for use as target-specific prodrug
06/11/2003EP1317554A2 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses tehreof
06/11/2003EP1317553A2 Pdes and uses thereof
06/11/2003EP1317543A1 Parietaria judaica ns-ltp antigen variants, uses thereof and compositions comprising them
06/11/2003EP1317540A2 Imidazoline receptor homologs
06/11/2003EP1317538A1 Novel compounds
06/11/2003EP1317537A2 G-csf analog compositions and methods
06/11/2003EP1317536A2 Tnf receptor-like molecules and uses thereof
1 ... 1829 1830 1831 1832 1833 1834 1835 1836 1837 1838 1839 1840 1841 1842 1843 1844 1845 1846 1847 1848 1849 ... 3163